225 related articles for article (PubMed ID: 11085591)
1. The survival motor neuron (SMN) protein: effect of exon loss and mutation on protein localization.
Le TT; Coovert DD; Monani UR; Morris GE; Burghes AH
Neurogenetics; 2000 Sep; 3(1):7-16. PubMed ID: 11085591
[TBL] [Abstract][Full Text] [Related]
2. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL
Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed human survival motor neurone isoforms, SMNDeltaexon7 and SMN+exon7, both form intranuclear gems but differ in cytoplasmic distribution.
Dodds E; Dunckley MG; Roberts RG; Muntoni F; Shaw CE
FEBS Lett; 2001 Apr; 495(1-2):31-8. PubMed ID: 11322942
[TBL] [Abstract][Full Text] [Related]
4. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
[TBL] [Abstract][Full Text] [Related]
5. Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing.
DiDonato CJ; Lorson CL; De Repentigny Y; Simard L; Chartrand C; Androphy EJ; Kothary R
Hum Mol Genet; 2001 Nov; 10(23):2727-36. PubMed ID: 11726560
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.
Monani UR; Lorson CL; Parsons DW; Prior TW; Androphy EJ; Burghes AH; McPherson JD
Hum Mol Genet; 1999 Jul; 8(7):1177-83. PubMed ID: 10369862
[TBL] [Abstract][Full Text] [Related]
7. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
[TBL] [Abstract][Full Text] [Related]
8. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients.
Andreassi C; Jarecki J; Zhou J; Coovert DD; Monani UR; Chen X; Whitney M; Pollok B; Zhang M; Androphy E; Burghes AH
Hum Mol Genet; 2001 Nov; 10(24):2841-9. PubMed ID: 11734549
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene.
Majumder S; Varadharaj S; Ghoshal K; Monani U; Burghes AH; Jacob ST
J Biol Chem; 2004 Apr; 279(15):14803-11. PubMed ID: 14742439
[TBL] [Abstract][Full Text] [Related]
10. SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1.
Young PJ; DiDonato CJ; Hu D; Kothary R; Androphy EJ; Lorson CL
Hum Mol Genet; 2002 Mar; 11(5):577-87. PubMed ID: 11875052
[TBL] [Abstract][Full Text] [Related]
11. Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype.
Sossi V; Giuli A; Vitali T; Tiziano F; Mirabella M; Antonelli A; Neri G; Brahe C
Eur J Hum Genet; 2001 Feb; 9(2):113-20. PubMed ID: 11313744
[TBL] [Abstract][Full Text] [Related]
12. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.
Lorson CL; Hahnen E; Androphy EJ; Wirth B
Proc Natl Acad Sci U S A; 1999 May; 96(11):6307-11. PubMed ID: 10339583
[TBL] [Abstract][Full Text] [Related]
13. Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.
Mattis VB; Rai R; Wang J; Chang CW; Coady T; Lorson CL
Hum Genet; 2006 Nov; 120(4):589-601. PubMed ID: 16951947
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.
Skordis LA; Dunckley MG; Yue B; Eperon IC; Muntoni F
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4114-9. PubMed ID: 12642665
[TBL] [Abstract][Full Text] [Related]
15. An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA.
Zhang ML; Lorson CL; Androphy EJ; Zhou J
Gene Ther; 2001 Oct; 8(20):1532-8. PubMed ID: 11704813
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
[TBL] [Abstract][Full Text] [Related]
17. Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs.
Madocsai C; Lim SR; Geib T; Lam BJ; Hertel KJ
Mol Ther; 2005 Dec; 12(6):1013-22. PubMed ID: 16226920
[TBL] [Abstract][Full Text] [Related]
18. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.
Hofmann Y; Wirth B
Hum Mol Genet; 2002 Aug; 11(17):2037-49. PubMed ID: 12165565
[TBL] [Abstract][Full Text] [Related]
19. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.
Le TT; Pham LT; Butchbach ME; Zhang HL; Monani UR; Coovert DD; Gavrilina TO; Xing L; Bassell GJ; Burghes AH
Hum Mol Genet; 2005 Mar; 14(6):845-57. PubMed ID: 15703193
[TBL] [Abstract][Full Text] [Related]
20. In vitro restoration of functional SMN protein in human trophoblast cells affected by spinal muscular atrophy by small fragment homologous replacement.
Sangiuolo F; Filareto A; Spitalieri P; Scaldaferri ML; Mango R; Bruscia E; Citro G; Brunetti E; De Felici M; Novelli G
Hum Gene Ther; 2005 Jul; 16(7):869-80. PubMed ID: 16000068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
